Post-transcriptional regulation of gene expression by alternative 5′-untranslated regions in carcinogenesis

Biochemical Society Transactions

Volumn 36, Issue 4, 2008, Pages 708-711

  Smith, Laura ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Carcinogenesis; Eukaryotic initiation factor (eIF); Gene expression; Oestrogen receptor (ER ); Tumour; Untranslated region (UTR)

Indexed keywords

ESTROGEN RECEPTOR BETA; GLUCOCORTICOID RECEPTOR; GLUCOCORTICOID RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR BETA; MESSENGER RNA; TRANSCRIPTOME;

5' UNTRANSLATED REGION; BREAST CANCER; CANCER THERAPY; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; GENE EXPRESSION REGULATION; HUMAN; ONCOLOGY; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVIEW; RNA TRANSCRIPTION; RNA TRANSLATION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; UPREGULATION;

5' UNTRANSLATED REGIONS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; ESTROGEN RECEPTOR ALPHA; HUMANS; RNA PROCESSING, POST-TRANSCRIPTIONAL;

EUKARYOTA; MAMMALIA;

EID: 49449110588     PISSN: 03005127     EISSN: None     Source Type: Journal    
DOI: 10.1042/BST0360708     Document Type: Review

References (33)

1. Stoneley, M. and Willis, A.E. (2003) Aberrant regulation of translation initiation in tumorigenesis. Curr. Mol. Med. 3, 597-603
2. Gray, N.K. and Wickens, M. (1998) Control of translation initiation in animals. Annu. Rev. Cell Dev. Biol. 14, 399-458
3. Kozak, M. (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAS. Nucleic Acids Res. 15, 8125-8148
4. Kozak, M. (1991) An analysis of vertebrate mRNA sequences: intimations of translational control. J. Cell Biol. 115, 987-903
5. Hughes, T.A (2007) 5′ untranslated regions: critical regulators of cap-dependent translation. in Leading-Edge Research Communications on Messenger RNA (Ostrovskiy, M.H., ed.), pp. 33-45, Nova Science Publishers, New York
6. Gelballe, A P. and Morris, D.R. (1994) Initiation codons within 5′-leaders of mRNAs as regulators of translation. Trends Biochem. Sci. 19, 159-164
7. Gray, N.K. and Hentze, M.W. (1994) Regulation of protein synthesis by mRNA structure, Mol. Biol. Rep. 19, 195-200
8. Derrigo, M., Cestalli, A, Savettieri, G. and Di Liegro, I. (2000) RNA-protein interactions in the control of stability and localization of messenger RNA. Int. J. Mol. Med. 5, 111-123
9. Hughes, T.A. (2006) Regulation of gene expression by alternative untranslated regions. Trends Genet. 22, 119-122
10. Duga, S., Asselta, R., Del Giacco, L., Malcovati, M., Ronchi, S., Tenchini, M.L. and Simonic, T. (1999) A new exon in the 5′ untranslated region of the connexin32 gene. Eur. J. Biochem. 259, 188-196
11. Hughes, T.A. and Brady, H.J.M. (2006) Regulation of axin-2 expression at the levels of transcription, translation and protein stability in lung and colon cancer. Cancer Lett. 233, 338-347
12. Sobczak, K. and Krzyzosiak, W.J. (2002) Structural determinants of BRCA1 translation regulation. J. Biol. Chem. 277, 17349-17358
13. Okumura, N., Saji, S., Eguchi, H., Nakashima, S. and Hayashi, S. (2002) Distinct promoter usage of mdm2 gene in human breast cancer. Oncol. Rep. 9, 557
14. Romeo, D.S., Park, K., Roberts, A.B., Sporn, M.B. and Kim, S.J. (1992) An element of the transforming growth-factor-β-1 5′-untranslated region represses translation and specifically binds a cytosolic factor. Mol. Endocrinol. 7, 759-766
15. Gomez-Martinez, A., Garcia-Morales, P., Carrato, A., Castro-Galache, M.D., Soto, J.L., Carrasco-Garcia, E., Garcia-Bautista, M., Guaraz, P., Ferragut, J.A. and Saceda, M. (2007) Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines. Mol. Cancer Res. 5, 641-653
16. Rhoads, R.E. Joshi-Barve, S. and Rinker-Schaeffer, C. (1993) Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis. Prog. Nucleic Acid Res Mol. Biol 46, 183-219
17. De Benedetti, A. and Graff, J. R. (2004) elF-4E expression and its role in malignancies and metastases. Oncogene 23, 3189-3199
18. Henderson, B.F., Ross, R. and Bernstein, L. (1988) Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation Award Lecture. Cancer Res. 48, 246-253
19. Zhao, C., Dahlman-Wright, K. and Gustafsson, J.-Å. (2008) Estrogen receptor β: an overview and update. Nucl. Recept. Signal. 6, e003
20. Speirs, V. (2002) Oestrogen receptor β in breast cancer: good, bad, or still too early to tell? J. Pathol. 197, 143-147
21. Hirata, S., Shoda, T., Kato, J. and Hoshi, K. (2001) The multiple untranslated first exons system of the human estrogen receptor β (FRβ) gene. J. Steroid Biochem. Mol. Biol. 78, 33-40
22. Bardin, A., Boulle, N., Lazennec, G., Vignon, F. and Pujol, P. (2004) Loss of ERβ expression as a common step in estrogen-dependent tumor progression. Endocr. Relat. Cancer 11, 537-551
23. Skliris, G.P, Munot, K., Bell, S.M., Carder, P.J., Lane, S., Horgan, K., Lansdown, M.R., Parkes, A.T., Hanby, A.M., Markham, A.F. and Speirs, V. (2003) Reduced expressiOn of oestrogen receptor β in invasive breast cancer and its re-expression using DNA methyl transferase inhibitors in a cell line model. J. Pathol. 201, 213-220
24. Gendra, E., Colgan, D.F., Meany, B. and Konarska, M.M. (2007) A sequence motif in the simian virus 40 (SV40) early core promoter affects alternative splicing of transcribed mRNA. J. Biol. Chem. 282, 11648-11657
25. Russcher, H., Dalm, V.A.S.H., de Jong, F.H., Brinkmann, A.O., Hofland, L.J., Lamberts, S.W.J. and Koper, J.W. (2007) Associations between promoter usage and alternative splicing of the glucocorticoid receptor gene. J. Mol. Endocrinol. 38, 91-98
26. Nobukuni, Y., Smith, C. L., Hager, G. L. and Detera-Wadleigh, S. D. (1995) Characterization of the human glucocorticoid receptor promoter. Biochemistry 34, 8207-8214
27. Breslin, M.B., Geng, C.D. and Vedeckis, W.V. (2001) Multiple promoters exist in the human GR gene one of which is activated by glucocorticoids. Mol. Endocrinol. 15, 1381-1395
28. Esslimani-Sahla, M., Simony-Lafontaine, J., Kramar, A., Lavaill, R., Mollevi, C., Warner, M., Gustafsson, J.-Å. and Rochefort, H. (2004) Estrogen receptor β (ERβ) level but not its ERβcx variant helps to predict tamoxifen resistance in breast cancer. Clin. Cancer Res. 10, 5769-5776
29. Vinayagam, R, Sibson, D.R., Holcombe, C., Aachi, V. and Davies, M.P. (2007) Association of oestrogen receptor β2 (ERβ2/ERβcx) with outcome of adjuvant endocrine treatment for primary breast cancer: a retrospective study. BMC Cancer 7, 131
30. Sugiura, H., Toyama, T., Hara, Y., Zhang, Z., Kobayashi, S., Fujii, Y., Iwase, H. and Yamashita, H. (2007) Expression of estrogen receptor β wild-type and its variant ERβcx/β2 is correlated with better prognosis in breast cancer. Jpn. J. Clin. Oncol. 37, 820-828
31. Martineau, Y., Le Bec, C., Monbrun, L., Allo, V., Chiu, I.M., Danos, O., Moine, H., Prats, H. and Prats, A.C. (2004) Internal ribosome entry site structural motifs conserved among mammalian fibroblast growth factor 1 alternatively spliced mRNAs. Mol. Cell. Biol. 24, 7622-7635
32. Pendleton, L.C., Goodwin, B.L., Flam, B.R., Solomonson, L.P. and Eichler, D.C. (2002) Endothelial argininosuccinate synthase mRNA 5′ untranslated region diversity: infrastructure for tissue specific expression, J. Biol. Chem. 277, 25363-25369
33. Sellers, R.S., Luchin, A.I., Richard, V., Brena, R.M., Lima, D. and Rosol, T.J. (2004) Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability. J. Mol. Endocrinol. 33, 227-241